Article

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma

Author and Disclosure Information

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is edited by Michael J. Murphy, MD, and reviewed by Anthony M. Rossi, MD. The future of highly targeted therapies for cancer is here, and for any clinician treating malignant melanoma, a solid understanding of these therapies is needed.


 

Next Article: